Medindia
Medindia LOGIN REGISTER
Advertisement

FDAnews Announces: 1 Week Until FDA Data Integrity Workshop, Oct. 30-31, 2018, San Francisco, CA

Wednesday, October 24, 2018 Drug News
Advertisement
Join award-winning FDA compliance expert, author and Cerulean founder John Avellanet for Data Integrity: The Key to FDA and GMP Compliance workshop. After two days of 'total immersion' study, attendees will return to their offices with a better understanding through team exercises and case studies and honest no-holds-barred discussions with John and their fellow attendees.
Advertisement

FALLS CHURCH, Va., Oct. 24, 2018 /PRNewswire-PRWeb/ -- FDA Data Integrity for Device and Pharma Firms, and Their Suppliers **Presented by FDAnews and Cerulean Associates LLC ** Oct. 30-31, 2018San Francisco, CA http://www.fdanews.com/fdadataintegrity
Advertisement

FDA Data Integrity starts in one week.

FDA gives simple instructions to its investigators: "If initial findings indicate the firm's electronic records may not be trustworthy and reliable … a more detailed evaluation may be warranted."

That's the polite way of saying this is when to expect to receive a warning letter.

With the increased scrutiny on data integrity, establishing internal competency and assessment programs is essential.

Join award-winning FDA compliance expert, author and Cerulean founder John Avellanet for the interactive workshop: Data Integrity for Device and Pharma Firms, and Their Suppliers. He is recognized globally for his business-savvy pragmatic advice and engaging speaking style.

During the 10 workshop sessions, attendees will:

  •     Identify likely risks and select the most appropriate controls
  •     Work to review audit trails and case study situations to determine the data integrity failures
  •     Review case study validation tests to see if data integrity is actually being verified
  •     See hundreds of questions and audit points to consider for internal and supplier audits
  •     Understand what departments need to be involved — who should take a leading role, how, and why
  •     Draft a personal business case and plan for implementing a data integrity control framework
  •     And much more

After two days of 'total immersion' study, attendees will return to their offices with increased understanding based on team exercises and case studies, informative, detailed explanations and honest no-holds-barred discussions with John and fellow attendees.

Reminder: FDA Data Integrity starts in one week.

Meet the Presenter: John Avellanet, Founder Cerulean Associates LLC

John Avellanet is an award-winning FDA compliance expert known for his business-savvy, pragmatic advice and engaging speaking style. Mr. Avellanet was the lead author of several certification courses on Good Manufacturing Practices (GMP) and Quality System Regulation (QSR) supplier management for the US Regulatory Affairs Professional Society.

Who Will Benefit:

  •     Executive management
  •     Regulatory affairs
  •     Quality assurance/quality control
  •     Legal and compliance officers
  •     Clinical research directors
  •     Consultants/service providers
  •     CAPA specialists
  •     Compliance information managers
  •     GMP compliance officers
  •     GMP training managers
  •     Heads of internal audits
  •     QA documentation managers
  •     QA/QC managers and directors
  •     Quality systems managers
  •     Systems analysts
  •     Training personnel
Conference Details FDA Data Integrity for Device and Pharma Firms, and Their Suppliers **Presented by FDAnews and Cerulean Associates LLC ** Oct. 30-31, 2018San Francisco, CA http://www.fdanews.com/fdadataintegrity

Tuition: Regular Pricing: $1,797 Significant team discounts are available.

Easy Ways to Register Online: http://www.fdanews.com/fdadataintegrity By phone: 888-838-5578 or 703-538-7600

About FDAnews FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDANEWS

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close